BridgeBio Pharma (BBIO) just delivered quarterly revenue that topped expectations, powered by stronger than anticipated U.S. sales of its cardiomyopathy drug Attruby, and the stock’s reaction shows ...

Monique Hinton rubbed her fingers together in one of her recent YouTube videos, signaling to her million-plus followers on the platform that she had a moneymaking business idea for them. She first ...

"I wasn't expecting any of this, and honestly, I don't think I'm a hero. I'm just a regular old person that just saw this ...

Over the past year, footage from the crash involving Trooper Waters has been featured in public safety messages highlighting ...

Dan Darkow, director of the Miller Center for Student Disability Services, credited with advocating for universal design ...

This strong performance was attributed to the robust sales of its ATTR-CM drug, Attruby, which generated $108.1 million in U.S. sales, exceeding both Goldman Sachs’ estimate of $92.3 million and ...

Investing.com - Bernstein SocGen Group initiated coverage on BridgeBio Pharma (NASDAQ:BBIO) with an Outperform rating and a $94.00 price target on Thursday, representing nearly 30% upside from the ...

Mommy vlogger Ruby Franke holds a camera with one hand and places her other hand around her son. He grins ear-to-ear as she announces the multi-day celebration that she has planned for his 10th ...

Lincoln police charge 3 accused of luring man to hotel room at Bally's to rob him Lincoln police said Monday that they arrested three people who they said robbed a man at Bally's Hotel Casino by ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...